Prosight Management
Latest statistics and disclosures from Prosight Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GLPG, MGTX, ADCT, KURA, ISRG, and represent 34.89% of Prosight Management's stock portfolio.
- Added to shares of these 10 stocks: ISRG (+$22M), CORCEPT THERAPEUTICS INC COMMON Stock cmn (+$12M), DXCM (+$8.4M), VRTX (+$8.0M), BSX (+$7.4M), SEM (+$6.7M), CON (+$6.2M), KIDS, IMVT, CDNA.
- Started 11 new stock positions in SDGR, ALGN, VRTX, AKRO, TBI, ISRG, PRCT, CORCEPT THERAPEUTICS INC COMMON Stock cmn, BSX, ACTU. TWST.
- Reduced shares in these 10 stocks: , GLPG (-$22M), FOLD (-$14M), ARGX (-$14M), ADCT (-$12M), BBIO (-$11M), MIRM (-$10M), ZYME (-$9.6M), CTMX (-$9.4M), ROIV (-$7.2M).
- Sold out of its positions in AXGN, ERAS, LNTH, MIRM, PEPG, UNH, LIVN, MURA.
- Prosight Management was a net seller of stock by $-82M.
- Prosight Management has $429M in assets under management (AUM), dropping by 4.56%.
- Central Index Key (CIK): 0001617201
Tip: Access up to 7 years of quarterly data
Positions held by Prosight Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Prosight Management
Prosight Management holds 42 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Galapagos Nv Spon Adr (GLPG) | 9.3 | $40M | -35% | 1.2M | 34.64 |
|
| Meiragtx Holdings (MGTX) | 7.8 | $34M | -10% | 4.1M | 8.23 |
|
| Adc Therapeutics Sa SHS (ADCT) | 7.0 | $30M | -28% | 7.5M | 4.00 |
|
| Kura Oncology (KURA) | 5.7 | $24M | -13% | 2.8M | 8.85 |
|
| Intuitive Surgical Com New (ISRG) | 5.1 | $22M | NEW | 49k | 447.23 |
|
| Janux Therapeutics (JANX) | 4.9 | $21M | 865k | 24.44 |
|
|
| Roivant Sciences SHS (ROIV) | 4.7 | $20M | -26% | 1.3M | 15.13 |
|
| Icon SHS (ICLR) | 4.5 | $19M | +11% | 110k | 175.00 |
|
| Syndax Pharmaceuticals (SNDX) | 3.6 | $15M | -7% | 1.0M | 15.38 |
|
| Bridgebio Pharma (BBIO) | 3.2 | $14M | -44% | 265k | 51.94 |
|
| Crinetics Pharmaceuticals In (CRNX) | 3.2 | $14M | +10% | 329k | 41.65 |
|
| Amicus Therapeutics (FOLD) | 3.1 | $14M | -50% | 1.7M | 7.88 |
|
| Dex (DXCM) | 3.1 | $13M | +178% | 195k | 67.29 |
|
| Shattuck Labs (STTK) | 3.0 | $13M | -17% | 5.5M | 2.39 |
|
| Zymeworks Del (ZYME) | 3.0 | $13M | -42% | 750k | 17.08 |
|
| Concentra Group Holdings Par Common Stock (CON) | 3.0 | $13M | +95% | 610k | 20.93 |
|
| Corcept Therapeutics Call Call Option | 2.9 | $12M | NEW | 148k | 83.11 |
|
| Immunovant (IMVT) | 2.6 | $11M | +45% | 699k | 16.12 |
|
| Select Medical Holdings Corporation (SEM) | 2.6 | $11M | +147% | 875k | 12.84 |
|
| Biohaven (BHVN) | 2.1 | $9.0M | +11% | 600k | 15.01 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.9 | $8.0M | NEW | 21k | 391.64 |
|
| Boston Scientific Corporation (BSX) | 1.7 | $7.4M | NEW | 76k | 97.63 |
|
| Caredx (CDNA) | 1.7 | $7.3M | +66% | 504k | 14.54 |
|
| Acadia Healthcare (ACHC) | 1.4 | $6.2M | +18% | 250k | 24.76 |
|
| Tectonic Therapeutic (TECX) | 1.4 | $6.0M | -14% | 379k | 15.69 |
|
| Orthopediatrics Corp. (KIDS) | 1.3 | $5.7M | +319% | 309k | 18.53 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.0 | $4.3M | -40% | 343k | 12.65 |
|
| Rocket Pharmaceuticals (RCKT) | 1.0 | $4.1M | -19% | 1.3M | 3.26 |
|
| Procept Biorobotics Corp (PRCT) | 0.6 | $2.7M | NEW | 77k | 35.69 |
|
| Align Technology (ALGN) | 0.6 | $2.4M | NEW | 19k | 125.22 |
|
| Argenx Se Sponsored Adr (ARGX) | 0.6 | $2.4M | -85% | 3.3k | 737.56 |
|
| Twist Bioscience Corp (TWST) | 0.5 | $2.1M | NEW | 75k | 28.14 |
|
| Akero Therapeutics (AKRO) | 0.4 | $1.9M | NEW | 39k | 47.48 |
|
| Cytomx Therapeutics (CTMX) | 0.4 | $1.8M | -83% | 565k | 3.19 |
|
| Sight Sciences (SGHT) | 0.4 | $1.5M | -49% | 440k | 3.44 |
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.2 | $737k | +67% | 268k | 2.75 |
|
| Schrodinger (SDGR) | 0.2 | $699k | NEW | 35k | 20.06 |
|
| Rein Therapeutics Com New (RNTX) | 0.2 | $650k | +32% | 568k | 1.15 |
|
| TrueBlue (TBI) | 0.1 | $487k | NEW | 80k | 6.13 |
|
| Prothena Corp SHS (PRTA) | 0.0 | $195k | -92% | 20k | 9.76 |
|
| Pliant Therapeutics (PLRX) | 0.0 | $30k | -97% | 21k | 1.48 |
|
| Actuate Therapeutics (ACTU) | 0.0 | $5.9k | NEW | 885.00 | 6.69 |
|
Past Filings by Prosight Management
SEC 13F filings are viewable for Prosight Management going back to 2017
- Prosight Management 2025 Q3 filed Nov. 14, 2025
- Prosight Management 2025 Q2 filed Aug. 14, 2025
- Prosight Management 2025 Q1 filed May 15, 2025
- Prosight Management 2024 Q4 filed Feb. 14, 2025
- Prosight Management 2024 Q3 filed Nov. 14, 2024
- Prosight Management 2024 Q2 filed Aug. 14, 2024
- Prosight Management 2024 Q1 filed May 15, 2024
- Prosight Management 2023 Q3 filed Nov. 14, 2023
- Prosight Management 2023 Q2 filed Aug. 14, 2023
- Prosight Management 2023 Q2 restated filed Aug. 14, 2023
- Prosight Management 2023 Q1 filed May 12, 2023
- Prosight Management 2022 Q4 filed Feb. 14, 2023
- Prosight Management 2022 Q3 filed Nov. 14, 2022
- Prosight Management 2022 Q2 filed Aug. 12, 2022
- Prosight Management 2022 Q1 filed May 16, 2022
- Prosight Management 2021 Q4 filed Feb. 14, 2022